A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs

PURPOSE: The advent of genomic diagnostic technologies such as next-generation sequencing has recently enabled the use of genomic information to guide targeted treatment in patients with cancer, an approach known as precision medicine. However, clinical outcomes, including survival and the cost of h...

Descripción completa

Detalles Bibliográficos
Autores principales: Haslem, Derrick S., Van Norman, S. Burke, Fulde, Gail, Knighton, Andrew J., Belnap, Tom, Butler, Allison M., Rhagunath, Sharanya, Newman, David, Gilbert, Heather, Tudor, Brian P., Lin, Karen, Stone, Gary R., Loughmiller, David L., Mishra, Pravin J., Srivastava, Rajendu, Ford, James M., Nadauld, Lincoln D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2017
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455156/
https://www.ncbi.nlm.nih.gov/pubmed/27601506
http://dx.doi.org/10.1200/JOP.2016.011486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455156/
https://www.ncbi.nlm.nih.gov/pubmed/27601506
http://dx.doi.org/10.1200/JOP.2016.011486

Ejemplares similares